Skip to main content
. 2023 Feb 9;9(4):519–526. doi: 10.1001/jamaoncol.2022.7605

Figure 3. Analyses of Overall and Disease-Free Survival According to Prognostic Baseline Factors.

Figure 3.

Hazard ratios (HRs) for age of 40 years or younger could not be estimated because of the small number of events. Allo-HCT indicates allogeneic hematopoietic stem cell transplant; ELN, European Leukemia Network; HLA, human leukocyte antigen; UD, unrelated donor.